Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hippo Holdings (HIPO) Cash & Equivalents (2020 - 2025)

Hippo Holdings (HIPO) has disclosed Cash & Equivalents for 6 consecutive years, with $198.9 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Cash & Equivalents fell 9.67% year-over-year to $198.9 million, compared with a TTM value of $198.9 million through Jun 2025, down 9.67%, and an annual FY2024 reading of $197.6 million, up 1.28% over the prior year.
  • Cash & Equivalents was $198.9 million for Q2 2025 at Hippo Holdings, up from $197.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $818.7 million in Q4 2021 and bottomed at $101045.0 in Q2 2021.
  • Average Cash & Equivalents over 5 years is $262.3 million, with a median of $234.6 million recorded in 2023.
  • Peak annual rise in Cash & Equivalents hit 321044.04% in 2022, while the deepest fall reached 70.14% in 2022.
  • Year by year, Cash & Equivalents stood at $818.7 million in 2021, then plummeted by 70.14% to $244.5 million in 2022, then dropped by 20.2% to $195.1 million in 2023, then grew by 1.28% to $197.6 million in 2024, then increased by 0.66% to $198.9 million in 2025.
  • Business Quant data shows Cash & Equivalents for HIPO at $198.9 million in Q2 2025, $197.6 million in Q4 2024, and $230.9 million in Q3 2024.